These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2651432)

  • 1. Incomplete factorial search for conditions leading to high quality crystals of Escherichia coli cytidine deaminase complexed to a transition state analog inhibitor.
    Betts L; Frick L; Wolfenden R; Carter CW
    J Biol Chem; 1989 Apr; 264(12):6737-40. PubMed ID: 2651432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Escherichia coli cytidine deaminase by a phosphapyrimidine nucleoside.
    Ashley GW; Bartlett PA
    J Biol Chem; 1984 Nov; 259(21):13621-7. PubMed ID: 6386818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phosphorus-containing pyrimidine analog as a potent inhibitor of cytidine deaminase.
    Ashley GW; Bartlett PA
    Biochem Biophys Res Commun; 1982 Oct; 108(4):1467-74. PubMed ID: 6758781
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of pyrimidin-2-one nucleosides as acid-stable inhibitors of cytidine deaminase.
    Kim CH; Marquez VE; Mao DT; Haines DR; McCormack JJ
    J Med Chem; 1986 Aug; 29(8):1374-80. PubMed ID: 3735306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallization and preliminary X-ray studies of D-serine dehydratase from Escherichia coli.
    Obmolova G; Tepliakov A; Harutyunyan E; Wahler G; Schnackerz KD
    J Mol Biol; 1990 Aug; 214(3):641-2. PubMed ID: 2201774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of chemical modification in the crystallization of isocitrate lyase from Escherichia coli.
    Abeysinghe SI; Baker PJ; Rice DW; Rodgers HF; Stillman TJ; Ko YH; McFadden BA; Nimmo HG
    J Mol Biol; 1991 Jul; 220(1):13-6. PubMed ID: 2067012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallization of yeast orotidine 5'-monophosphate decarboxylase complexed with 1-(5'-phospho-beta-D-ribofuranosyl) barbituric acid.
    Bell JB; Jones ME; Carter CW
    Proteins; 1991; 9(2):143-51. PubMed ID: 2008434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex.
    Betts L; Xiang S; Short SA; Wolfenden R; Carter CW
    J Mol Biol; 1994 Jan; 235(2):635-56. PubMed ID: 8289286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and properties of cytidine deaminase from escherichia coli.
    Ashley GW; Bartlett PA
    J Biol Chem; 1984 Nov; 259(21):13615-20. PubMed ID: 6386817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization and preliminary X-ray diffraction studies on the mutT nucleoside triphosphate pyrophosphohydrolase of Escherichia coli.
    Bessman MJ; Bullions LC; Bhatnagar SK; Braden BC; Love WE
    J Biol Chem; 1991 May; 266(14):9055-6. PubMed ID: 1851163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytidine deaminases from B. subtilis and E. coli: compensating effects of changing zinc coordination and quaternary structure.
    Carlow DC; Carter CW; Mejlhede N; Neuhard J; Wolfenden R
    Biochemistry; 1999 Sep; 38(38):12258-65. PubMed ID: 10493793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallization and preliminary X-ray analysis of bacterial cytosine deaminase.
    Ireton GC; Black ME; Stoddard BL
    Acta Crystallogr D Biol Crystallogr; 2001 Nov; 57(Pt 11):1643-5. PubMed ID: 11679731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of pyrimidin-2-one ribonucleoside by cytidine deaminase as the transition-state analogue 3,4-dihydrouridine and the contribution of the 4-hydroxyl group to its binding affinity.
    Frick L; Yang C; Marquez VE; Wolfenden R
    Biochemistry; 1989 Nov; 28(24):9423-30. PubMed ID: 2692708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallization of succinyl-CoA synthetase from Escherichia coli.
    Wolodko WT; James MN; Bridger WA
    J Biol Chem; 1984 Apr; 259(8):5316-20. PubMed ID: 6371002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallization and preliminary crystallographic analysis of Bacillus subtilis guanine deaminase.
    Chang YJ; Huang CH; Hu CY; Liaw SH
    Acta Crystallogr D Biol Crystallogr; 2004 Jun; 60(Pt 6):1152-4. PubMed ID: 15159585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallization and preliminary X-ray crystallographic analysis of pyridoxine 5'-phosphate oxidase complexed with flavin mononucleotide.
    Musayev FN; Safo MK; Di Salvo ML; Schirch V; Abraham DJ
    J Struct Biol; 1999 Aug; 127(1):88-91. PubMed ID: 10479623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 1-beta-D-ribofuranosyl-1,2-dihydropyrimidin-2-one derivatives and their biological activities.
    Maeda M; Kaneko C; Uchida NA; Sasaki T
    Nucleic Acids Symp Ser; 1985; (16):77-80. PubMed ID: 4088888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New crystal form of recombinant murine interferon-beta.
    Matsuda S; Senda T; Itoh S; Kawano G; Mizuno H; Mitsui Y
    J Biol Chem; 1989 Aug; 264(23):13381-2. PubMed ID: 2668265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization and preliminary X-ray studies of Escherichia coli glycerol kinase.
    Faber HR; Pettigrew DW; Remington SJ
    J Mol Biol; 1989 Jun; 207(3):637-9. PubMed ID: 2547969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallization and preliminary x-ray characterization of thioredoxin reductase from Escherichia coli.
    Kuriyan J; Wong L; Russel M; Model P
    J Biol Chem; 1989 Aug; 264(22):12752-3. PubMed ID: 2666412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.